SCHEMBL695528

SCHEMBL695528

Cc1nn(CCc2ccccc2)c(N2CCCC2C(=O)O)c1S(=O)(=O)c1ccccc1Cl

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CCR4 P51679 2/20 0.36
ACE P12821 2/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
MMP1 P03956 1/20 0.35
MMP7 P09237 1/20 0.35
MMP8 P22894 1/20 0.35
MMP12 P39900 1/20 0.35
MMP13 P45452 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
FKBP1A P62942 3/20 0.35
KEAP1 Q14145 1/20 0.34
OPRM1 P35372 1/20 0.34
CHRM4 P08173 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3724272 0.95 FKBP1A (0.37) ALDH1A1KMT2AFKBP1A
SCHEMBL696150 0.92 FKBP1A (0.40) CCR4ALDH1A1HPGDNPC1RAB9A
SCHEMBL3719340 0.90 RAB9A (0.37) CCR4RAB9AMEN1KMT2AKEAP1
SCHEMBL696225 0.88 KMT2A (0.37) ALDH1A1MEN1KMT2A
SCHEMBL695772 0.86 ALDH1A1 (0.41) ACEALDH1A1HPGDNPC1RAB9A
SCHEMBL3721306 0.83 CTSS (0.34) ALDH1A1HPGDKMT2AKEAP1CHRM4
SCHEMBL696054 0.83 ACE (0.37) ACEALDH1A1HPGDNPC1RAB9A
SCHEMBL694457 0.82 AADAT (0.36) KEAP1CHRM4
SCHEMBL696136 0.81 AADAT (0.39) HPGDKEAP1CHRM4
SCHEMBL690481 0.79 TSHR (0.36) ALDH1A1HPGDKMT2ACHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421826-A1 PROLINE DERIVATIVES AS CATHEPSIN INHIBITORS F. Hoffmann-La Roche AG (CH) 2012-02-29 EP disclosed
WO-2010121918-A1 PROLINE DERIVATIVES AS CATHEPSIN INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2010-10-28 WO disclosed